Behavioral and psychological signs and symptoms of dementia (BPSD) in antipsychotic-naive Alzheimer's disease patients

被引:17
|
作者
Suh, GH [1 ]
Kim, SK [1 ]
机构
[1] Hallym Univ, Med Ctr, Hangang Sacred Heart Hosp, Dept Psychiat, Seoul 150030, South Korea
关键词
Alzheimer's disease; dementia; old age; BEHAVE-AD; BPSD; antipsychot;
D O I
10.1017/s1041610204000432
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background/Objective: There were few studies identifying the natural unfolding of behavioural and psychological symptoms of dementia (BPSD) in the course of Alzheimer's disease (AD) progression in antipsychotic-naive AD patients. This study aims to examine the specific nature of the association between BPSD in AD and the global severity of illness measured by Global Deterioration Scale(GDS) in antipsychotic-naive AD patients in Korea. Methods: A total of 562 antipsychotics-naive AD patients were recruited from four different groups [a geriatric mental hospital (n = 145), a semi-hospitalized dementia institution (n = 120), a dementia clinic ( n = 114) and community-dwelling dementia patients (n = 183)]. BPSD exhibited by AD patients were measured using the 25-item Korean version of the BEHAVE-AD. Results: Ninety-two percent (n = 517) of AD patients had at least one BPSD, while 56% (n=315) had 4 or more BPSD. Specific kinds of behavioral disturbance peak at the stages of moderate AD (GDS stage 5) or moderately severe AD (GDS stage 6). AD patients left at home without any treatment had higher frequency of BPSD than did other groups seeking treatment, although all of them were antipsychotic-naive. Conclusion: BPSD potentially remediable to treatment were highly frequent in Korean AD patients. Health policies to meet the unmet needs of elderly Koreans are urgently needed, especially for AD patients at home without treatment.
引用
收藏
页码:337 / 350
页数:14
相关论文
共 50 条
  • [21] Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD)
    Gareri, P
    Cotroneo, A
    Lacava, R
    Seminara, G
    Marigliano, N
    Loiacono, A
    De Sarro, G
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2004, : 207 - 215
  • [22] Editorial: Pharmacology of BPSD (Behavioral and Psychological Symptoms of Dementia)
    Gimenez-Llort, Lydia
    Johansson, Bjorn
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [23] A cross-sectional study of the behavioural and psychological symptoms of dementia (BPSD) in 435 patients with Alzheimer's disease
    Mirakhur, A
    Craig, D
    Hart, DJ
    McIlroy, SP
    Passmore, P
    NEUROBIOLOGY OF AGING, 2004, 25 : S106 - S106
  • [24] Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
    Calsolaro, Valeria
    Femminella, Grazia Daniela
    Rogani, Sara
    Esposito, Salvatore
    Franchi, Riccardo
    Okoye, Chukwuma
    Rengo, Giuseppe
    Monzani, Fabio
    PHARMACEUTICALS, 2021, 14 (03)
  • [25] Psychosocial interventions in behavioral and psychological symptoms of dementia (BPSD)
    Brodaty, H
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 17 - 17
  • [26] Behavioral signs and symptoms in patients with Alzheimer's and vascular dementia.
    Steinberger, E
    Baumgarten, M
    GERONTOLOGIST, 2001, 41 : 110 - 110
  • [27] The relationship? Between premorbid personality and the behavioural and psychological symptoms of dementia (BPSD) in patients with Alzheimer's disease (AD)
    Archer, N
    Boothby, H
    Brown, R
    Foy, C
    Nicholas, H
    Poppe, M
    Shabbir, S
    Lovestone, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S305 - S305
  • [28] Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)
    Liperoti, Rosa
    Pedone, Claudio
    Corsonello, Andrea
    CURRENT NEUROPHARMACOLOGY, 2008, 6 (02) : 117 - 124
  • [29] Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease
    Monji, Akira
    Takita, Masashi
    Samejima, Takaaki
    Takaishi, Toshihiro
    Hashimoto, Kazuhito
    Matsunaga, Hiroyuki
    Oda, Mariko
    Sumida, Yasuhisa
    Mizoguchi, Yoshito
    Kato, Takahiro
    Horikawa, Hideki
    Kanba, Shigenobu
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (02): : 308 - 311
  • [30] Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease
    Finkel, SI
    CLINICAL THERAPEUTICS, 2004, 26 (07) : 980 - 990